1. Home
  2. OGN vs DAC Comparison

OGN vs DAC Comparison

Compare OGN & DAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Organon & Co.

OGN

Organon & Co.

SELL

Current Price

$13.76

Market Cap

3.6B

Sector

Health Care

ML Signal

SELL

Logo Danaos Corporation

DAC

Danaos Corporation

HOLD

Current Price

$158.31

Market Cap

3.0B

ML Signal

HOLD

Company Overview

Basic Information
Metric
OGN
DAC
Founded
1923
1972
Country
United States
Greece
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Marine Transportation
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
3.6B
3.0B
IPO Year
2020
2006

Fundamental Metrics

Financial Performance
Metric
OGN
DAC
Price
$13.76
$158.31
Analyst Decision
Hold
Strong Buy
Analyst Count
5
2
Target Price
$11.25
★ $164.50
AVG Volume (30 Days)
★ 2.0M
147.8K
Earning Date
11-09-2026
11-16-2026
Dividend Yield
0.58%
★ 2.28%
EPS Growth
N/A
★ N/A
EPS
★ 0.95
N/A
Revenue
★ $6,216,000,000.00
N/A
Revenue This Year
N/A
$3.24
Revenue Next Year
$2.51
$1.63
P/E Ratio
$14.48
★ $4.01
Revenue Growth
N/A
★ N/A
52 Week Low
$5.69
$87.62
52 Week High
$13.83
$172.76

Technical Indicators

Market Signals
Indicator
OGN
DAC
Relative Strength Index (RSI) 54.03 49.85
Support Level $13.46 $151.00
Resistance Level $13.77 $163.64
Average True Range (ATR) 0.04 3.81
MACD -0.00 -1.14
Stochastic Oscillator 34.78 23.36

Price Performance

Historical Comparison
OGN
DAC

About OGN Organon & Co.

Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.

About DAC Danaos Corporation

Danaos Corp is an international owner of containerships. It provides international seaborne transportation services by operating vessels in the containership sector of the shipping industry. The company's customers include HMM, MSC, Yang Ming, Hapag Lloyd, ZIM, Maersk, COSCO, OOCL, ONE, PIL, Sealead, Niledutch, Samudera, OSC, and Arkas. Geographically, the company operates in Australia, Asia, Europe, and America, with maximum revenue from the Australia-Asia region. It has two reporting segments: Container vessels and Drybulk vessels segment. It generates the majority of its revenue from Container vessels.

Share on Social Networks: